U.S. 5G Connected Medical Devices Market: $84.7B, 22% CAGR

Market Outlook

By 2032, the U.S. 5G Connected Medical Devices Market is projected to reach approximately USD 84.72 billion, expanding at a CAGR of 22.41% during the forecast period 2027–2032. The market stood at USD 25.18 billion in 2026, following historical values of approximately USD 11.45 billion in 2023, USD 14.88 billion in 2024, and USD 19.35 billion in 2025. Values in this report are expressed in USD billions.

The U.S. 5G connected medical devices industry sits at the convergence of high-bandwidth clinical telecommunications, mission-critical decentralized care, advanced biomedical sensor engineering, edge artificial intelligence, enterprise hospital cloud infrastructure, and federal spectrum modernizations. Demand is underpinned by an unprecedented structural migration of acute, sub-acute, and ambulatory medical interventions from centralized brick-and-mortar hospital facilities into community networks, connected outpatient hubs, and domestic home environments. In 2024, over 133 million American citizens lived with one or more chronic conditions, generating a clinical and economic imperative for persistent, high-fidelity physiological monitoring. Concurrently, national healthcare expenditures in the United States approached USD 4.90 trillion in 2024, with institutional acute inpatient care and post-acute readmissions accounting for more than USD 1.45 trillion of aggregate expenditures. To curtail preventable rehospitalizations, mitigate clinical labor depletion, and optimize capital utilization under value-based payment models, hospital purchasing groups and integrated delivery networks have accelerated capital investments into fifth-generation cellular medical hardware.

The clinical profile of connected patient care has transitioned from intermittent, episodic asynchronous data capture toward continuous, multi-parametric, real-time closed-loop physiological streaming. Legacy short-range radio protocols such as Bluetooth Low Energy, conventional Wi-Fi, and proprietary sub-gigahertz RF systems frequently suffer from severe radiofrequency packet collision, signal dropouts, limited building penetration, complex patient provisioning barriers, and acute cybersecurity vulnerabilities across non-managed domestic and public networks. By embedding native 3GPP-standardized 5G chipsets—particularly Release 16, Release 17 Reduced Capability, and Release 18 5G-Advanced architectures—directly into wearable biosensors, point-of-care ultrasound consoles, external infusion systems, continuous glucose monitors, and surgical displays, medical device manufacturers have established uncompromised cellular lifelines. These 5G medical systems leverage ultra-reliable low-latency communication delivering air-interface latencies below 10 milliseconds, massive machine-type communications capable of supporting up to one million concurrent connections per square kilometer, and enhanced mobile broadband delivering multi-gigabit per second data transfer speeds.

The consolidation of private acute healthcare facilities into multi-state integrated delivery networks has fundamentally redefined hospital capital procurement behavior. Enterprise health systems now mandate that capital equipment procurements demonstrate absolute interoperability with electronic health record cores, native cloud-edge analytical platforms, zero-trust network security postures, and carrier-agnostic cellular private networks. Capital expenditure committees are systematically phasing out depreciated legacy medical telemetry systems that operate within overcrowded, unlicensed 2.4 GHz and 5 GHz Wi-Fi spectrum bands. Instead, capital allocations are funneling into dedicated private 5G cellular systems utilizing Citizens Broadband Radio Service OnGo shared spectrum between 3.55 GHz and 3.70 GHz alongside licensed mid-band spectrum. This architectural pivot provides guaranteed quality of service, automated clinical traffic prioritization through dynamic network slicing, and complete physical and logical isolation of life-critical physiological data streams from public internet congestion.

Concurrently, the historical reliance on external paired cellular hubs, physical dongles, and smartphone smartphone-dependent companion applications is receding. Managing physical dongles and secondary consumer smartphones introduces profound points of failure in acute and ambulatory monitoring workflows, including patient Bluetooth pairing errors, operating system background process terminations, battery exhaustion, and non-compliance. Purpose-engineered 5G medical devices integrate native embedded eSIMs, integrated multi-band microstrip antenna arrays, and energy-optimized baseband processors that connect autonomously to carrier macro networks or hospital enterprise private RANs immediately upon patient activation. These self-contained connected platforms eliminate patient operational friction, maximize clinical data adherence rates, elevate compliance monitoring metrics above 94%, and dramatically lower post-deployment technical support overhead for virtual care service providers.

The historical market expanded rapidly from 2023 through 2025 as enterprise health systems deployed emergency federal infrastructure capital, integrated post-pandemic remote patient monitoring programs into standard operating procedures, and upgraded ambulance fleets with cellular vehicle-to-everything emergency medical telematics. From 2027 onward, market growth will be driven by the clinical commercialization of 5G Reduced Capability medical silicon, widespread deployment of enterprise private 5G networks across tier-one trauma and academic hospital centers, autonomous edge-AI diagnostic ultrasound and digital pathology transmission, real-time augmented reality surgical visualization, continuous closed-loop wearable insulin and drug delivery systems, and expanding reimbursement coverage across Medicare and commercial payer schedules for continuous biometric telemetry.

Introduction

According to the U.S. 5G Connected Medical Devices Market Report, high-bandwidth, ultra-low-latency cellular biomedical engineering represents one of the most critical transformation vectors within the American medical technology landscape. The clinical continuum in the United States is navigating a permanent shift toward evidence-based, decentralized healthcare delivery. A patient traversing the contemporary care continuum may initiate biometric tracking at home using an automated, 5G-embedded wearable hemodynamic patch, experience an acute cardiovascular exacerbation requiring pre-hospital ultrasound and real-time 12-lead ECG tele-transmission within an emergency 5G connected ambulance, undergo minimally invasive robotic surgery guided by cloud-edge computing inside an enterprise private 5G hospital suite, and complete post-operative convalescence within a hospital-at-home program overseen by continuous 5G telemetry and smart infusion therapy.

This interconnected clinical continuum establishes an exceptional commercial ecosystem characterized by substantial initial hardware capital deployments paired with high-margin, recurring cellular connectivity and software-as-a-service revenues. Wearable biosensors and remote patient monitoring devices form the numerical and procedural foundation of outpatient clinical revenue, while diagnostic imaging platforms, emergency mobile telemetry systems, and surgical assist consoles represent the premier capital expenditure categories across enterprise hospital networks, ambulatory surgery centers, and municipal EMS authorities. The operational economics of contemporary American healthcare providers mandate that connected medical devices demonstrate rapid clinical ROI, frictionless patient onboarding, total immunity to RF signal interference, and automated charting compliance with major electronic health record platforms such as Epic, Cerner Oracle, and MEDITECH.

The modernization of Centers for Medicare and Medicaid Services reimbursement frameworks has structurally altered the financial viability and enterprise adoption thresholds of connected medical devices. The codification and progressive expansion of Remote Physiological Monitoring and Remote Therapeutic Monitoring Current Procedural Terminology codes—specifically CPT codes 99453, 99454, 99457, 99458, 98975, 98976, 98977, 98980, and 98981—have created predictable, fee-for-service cash flows for clinical practices managing chronic hypertension, congestive heart failure, diabetes, and chronic obstructive pulmonary disease outside clinic walls. Furthermore, under the Hospital Readmissions Reduction Program and value-based bundled payment contracts, health systems face severe financial penalties if heart failure, myocardial infarction, or pneumonia patients suffer unmanaged 30-day readmissions. Deploying cellular 5G medical devices that stream physiological trend data without relying on the patient’s home Wi-Fi network ensures uninterrupted data flow, empowering clinical care teams to detect decompensation days before catastrophic clinical failure occurs.

Hospital and outpatient clinic operations face profound operational labor constraints, marked by persistent nursing shortages, physician burnout, and clinical technician recruitment bottlenecks. Healthcare providers require medical hardware that automates continuous surveillance, eliminates manual vital signs charting, and executes automated triage via machine learning algorithms. In legacy inpatient environments, clinical staff expend substantial manual labor recording episodic vitals and troubleshooting dropped Wi-Fi connections on mobile telemetry carts. Modern 5G-enabled patient monitors, smart beds, and wearable sensors continuously stream high-frequency physiological waveforms directly into hospital central monitoring consoles and mobile nurse communication badges, eliminating human documentation latency and liberating nursing staff for high-touch bedside interventions.

The market environment is further characterized by the aggressive modernization of pre-hospital emergency medical services. Municipal fire departments, private emergency ambulance providers, and regional trauma networks across the United States are upgrading conventional basic life support and advanced life support emergency vehicles into connected mobile care pods. Ruggedized 5G emergency gateways, mobile multi-parameter monitors, point-of-care blood analyzers, and portable ultrasound scanners allow paramedics to transmit high-definition video, live biometrics, and multi-slice mobile CT neuroimaging scans to on-call hospital stroke teams and trauma surgeons while in transit. This high-bandwidth, sub-10-millisecond cellular connection bridges the critical pre-hospital operational window, enabling emergency departments to administer targeted thrombolytic therapies or prep catheterization laboratories before the patient physically arrives.

From 2027 through 2032, medical device manufacturers will compete across tightly unified hardware, connectivity, and data analytics ecosystems. Leading medtech vendors are moving away from selling isolated standalone medical hardware toward end-to-end device-to-cloud clinical platforms. Tier-one vendors are embedding cellular 5G modules directly at the printed circuit board level, negotiating bulk nationwide data agreements with commercial telecommunication carriers, securing private cellular spectrum licensing, and certifying devices under rigorous Food and Drug Administration cybersecurity guidelines. The market leaders will be those that achieve seamless clinical workflow integration, guaranteed regulatory compliance, bulletproof data encryption, and transparent clinical utility across acute, ambulatory, and domestic healthcare environments.

Key Market Drivers: What’s Fueling the U.S. 5G Connected Medical Devices Market Boom?

The first primary growth driver is the rapid institutionalization of Hospital-at-Home and high-acuity decentralized remote patient monitoring programs across the United States healthcare system. Driven by acute inpatient bed capacity constraints, exorbitant overhead costs associated with physical hospital stays, and consumer demand for domestic convalescence, major integrated delivery networks have scaled virtual hospital wards. Patients admitted to virtual acute wards present with severe, fluctuating conditions, including acute exacerbations of heart failure, severe cellulitis, stable pulmonary embolisms, and post-surgical recovery. Managing these high-acuity patients safely outside hospital walls requires an unbreakable data link capable of transmitting multi-channel telemetry, continuous pulse oximetry, core body temperature, and automated medication delivery logs without transmission latency or connection dropouts. Legacy domestic Wi-Fi networks in American households are inherently unreliable, subject to consumer network reboots, incorrect WPA passkeys, RF attenuation through construction materials, and bandwidth throttling from domestic video streaming. Native 5G-connected medical devices bypass domestic residential network configurations entirely, establishing an encrypted, carrier-grade cellular connection directly to hospital clinical operations centers the instant the device is powered on, securing uncompromised patient safety and continuous clinical oversight.

A second driver is the acute, nationwide shortage of registered nurses, respiratory therapists, and specialized clinical staff across American healthcare systems. The American healthcare labor landscape faces structural deficits that threaten hospital operational solvency and inpatient capacity. In response, hospital executives are actively deploying virtual nursing programs and centralized hospital telemetry command centers, wherein a small cohort of specialized critical care nurses remotely monitors hundreds of inpatient beds across multiple geographic hospital facilities. This clinical centralization model requires continuous, uncompressed high-fidelity waveform telemetry, including continuous ECG waveforms, invasive arterial pressure tracings, capnography curves, and high-definition video feeds of the patient. Legacy hospital Wi-Fi networks frequently struggle with the packet congestion and signal interference generated by thousands of concurrent smart phones, visitor tablets, and legacy medical hardware competing for unlicensed 2.4 GHz and 5 GHz spectrum. Enterprise private 5G cellular networks operating on dedicated Citizens Broadband Radio Service spectrum provide clean, interference-free wireless infrastructure with dedicated bandwidth slicing, ensuring that life-critical patient monitoring streams never drop or buffer, thereby enabling virtual nurses to manage broad patient cohorts with clinical safety and operational efficiency.

A third driver is the rapid adoption of value-based healthcare reimbursement frameworks and federal financial penalties tied to patient readmissions. The Centers for Medicare and Medicaid Services administers the Hospital Readmissions Reduction Program, which penalizes hospitals up to 3% of their total Medicare inpatient reimbursement if their 30-day all-cause readmission rates for specific conditions exceed national benchmarks. Concurrently, commercial health insurance payers and Medicare Advantage organizations are shifting commercial contracts toward shared-savings and capitated risk models. Under these financial structures, hospital systems bear direct financial liability for clinical complications and emergency department visits occurring within 30 to 90 days following hospital discharge. Deploying 5G-connected continuous biometric monitors, cellular smart weight scales, connected continuous positive airway pressure devices, and automated cellular medication adherence dispensers directly mitigates readmission risk. Clinical care coordinators receive real-time, algorithmic alerts regarding fluid retention, cardiac arrhythmias, or respiratory degradation days before a patient becomes symptomatic, allowing for proactive pharmacological adjustments that prevent costly rehospitalizations.

A fourth driver is the commercial availability of 5G Reduced Capability chipsets and ultra-low-power biomedical sensor silicon. The original 3GPP 5G New Radio specifications were heavily optimized for ultra-high-throughput consumer smartphones and complex industrial automation, requiring bulky multi-antenna arrays, massive power consumption, and expensive silicon chipsets that were impractical for small, battery-operated, disposable or short-wear-time medical devices. The formal introduction and commercialization of 3GPP Release 17 and Release 18 5G RedCap specifications have bridged this critical technological divide. 5G RedCap lowers device complexity by reducing baseband bandwidth, decreasing the number of required device receive antennas to one or two, and integrating advanced power-saving architectures such as Extended Discontinuous Reception and Radio Resource Management relaxation. These engineering breakthroughs enable medical device manufacturers to integrate native 5G cellular transceivers into ultra-compact, featherweight wearable patches, smart biosensors, and portable diagnostic tools with multi-week or multi-month battery lifespans, eliminating the cost and form-factor barriers that previously constrained cellular medical device engineering.

A fifth driver is the digital transformation of Emergency Medical Services and the widespread deployment of mobile integrated healthcare and stroke ambulance units. In time-sensitive clinical emergencies such as acute ischemic strokes, ST-elevation myocardial infarctions, and severe poly-trauma, patient survival and long-term neurological morbidity are directly governed by the speed of clinical diagnosis and targeted intervention. Modern mobile stroke units and advanced life support ambulances are equipped with specialized point-of-care mobile CT scanners, 12-lead diagnostic ECG monitors, portable whole-body ultrasound systems, and multi-angle high-definition video tele-consultation systems. Transmitting massive cross-sectional neuroimaging CT scan DICOM data sets—which often exceed 800 megabytes per patient—from a moving ambulance to an on-call hospital neurosurgeon requires substantial uplink bandwidth and rock-solid mobility handovers between cellular base stations. High-bandwidth 5G macro networks provide the gigabit-tier uplink speeds and ultra-low latency necessary to transmit full CT datasets and real-time hemodynamic streams in seconds, enabling hospital surgical teams to confirm stroke etiology and prepare operating suites before the ambulance arrives at the bay.

A sixth driver is the implementation of rigorous federal regulatory mandates regarding medical device cybersecurity and wireless coexistence. In recent years, the FDA has dramatically elevated pre-market cybersecurity expectations for cyber devices under Section 524B of the Federal Food, Drug, and Cosmetic Act. Medical device manufacturers must demonstrate that their connected hardware incorporates robust software bills of materials, zero-trust cryptographic verification, secure boot architectures, and validated wireless coexistence capabilities to prevent dangerous radio interference in dense RF environments. Enterprise hospital IT leaders are increasingly resistant to onboarding thousands of disparate, unmanaged medical devices onto enterprise Wi-Fi networks due to the pervasive threat of lateral ransomware propagation and the operational complexity of maintaining individual WPA2/WPA3 enterprise device certificates. In contrast, 5G cellular architectures integrate hardware-based Subscriber Identity Module cryptographic authentication, 256-bit air-interface encryption, complete physical separation from local enterprise hospital IT subnets, and dedicated private cellular APNs, providing hospital Chief Information Security Officers with a zero-trust, enterprise-grade security framework that dramatically accelerates hospital IT procurement approvals.

Finally, the explosive clinical growth of artificial intelligence and computer-vision algorithms at the point of care drives sustained demand for high-throughput, low-latency medical device connectivity. Modern point-of-care ultrasound devices, handheld digital dermatoscopes, continuous cardiac telemetry sensors, and surgical endoscopic cameras are increasingly paired with complex deep neural networks that assist clinicians in identifying cardiac ejection fractions, occult hemorrhages, malignant skin lesions, and anatomical resection margins. Executing these computationally heavy artificial intelligence inference models directly on battery-operated, handheld medical hardware is severely constrained by thermal dissipation limits and battery capacity. High-bandwidth 5G networks paired with Multi-Access Edge Computing servers deployed at the hospital campus or cellular base station resolve this physical dilemma. Handheld 5G medical devices instantly stream raw, uncompressed video frames and high-frequency physiological data to local edge servers, where deep learning algorithms process the data and return diagnostic guidance overlays to the clinician’s display with latency below 15 milliseconds, delivering supercomputing diagnostic power directly into portable, battery-efficient clinical hardware.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation across the U.S. 5G connected medical devices market is fundamentally transforming conventional standalone biomedical hardware into intelligent, highly integrated, hyper-connected diagnostic and therapeutic platforms. Competitive advantage within the medical technology landscape has moved decisively beyond isolated mechanical specifications, physical enclosures, or raw sensor accuracy toward integrated systems that fuse advanced millimeter-wave and sub-6 GHz RF engineering, embedded hardware cryptography, real-time edge AI inference, and autonomous electronic health record interoperability.

In wearable physiological monitoring, the architectural migration toward native 5G RedCap biomedical silicon represents an engineering breakthrough. Leading medical sensor manufacturers are integrating single-die system-on-chip architectures that combine biomedical analog front-ends, low-power ARM Cortex microcontrollers, and integrated 5G baseband modems into miniature, flexible, skin-adherent elastomer patches. These fifth-generation biosensors incorporate advanced microstrip antenna geometries engineered directly into the flexible printed circuit board, resolving the severe RF impedance mismatch and signal attenuation historically caused by the dielectric properties of human skin and subcutaneous tissue. Furthermore, these smart patches leverage ultra-low-power physiological algorithms that execute continuous, multi-lead ECG arrhythmia analysis, photoplethysmographic oxygen saturation tracking, respiratory acoustic impedance, and skin temperature monitoring directly at the sensor level, dynamically modulating cellular radio transmissions based on clinical acuity to extend single-charge operating lifespans beyond 14 continuous days.

Diagnostic ultrasound engineering has experienced an innovation leap through the integration of 5G enhanced mobile broadband modems and edge-computed synthetic aperture beamforming into ultra-portable, handheld transducers. Contemporary point-of-care ultrasound devices bypass heavy console hardware entirely, utilizing piezoelectric micromachined ultrasonic transducers that interface wirelessly with 5G networks. In emergency trauma triage, rural health clinics, and mobile disaster response, clinicians capture high-frame-rate, multi-channel volumetric ultrasound clips that are beamed over private or public 5G networks to multi-access edge computing nodes. Edge-deployed deep learning algorithms instantly quantify cardiac stroke volume, detect internal abdominal bleeding via automated Focused Assessment with Sonography for Trauma protocols, and stream synchronized, high-definition ultrasound cine-loops to remote tertiary cardiologists with imperceptible latency, democratizing specialized diagnostic imaging across geographically isolated and frontline care settings.

Inpatient critical care telemetry and bedside patient monitoring workstations are being completely re-engineered around private 5G Citizens Broadband Radio Service network compatibility. Tier-one patient monitoring vendors are integrating dual-SIM, carrier-agnostic 5G radio modules directly into modular bedside monitors, transport monitors, and centralized telemetry transmitters. These next-generation clinical workstations utilize dynamic 5G network slicing, an advanced telecommunications architecture that partitions a single physical 5G radio network into multiple virtual, logically isolated networks tailored to specific clinical data characteristics. Life-critical physiological alert streams and real-time defibrillator telemetry are assigned to ultra-reliable, deterministic network slices that guarantee sub-5-millisecond latency and zero packet loss, completely insulating vital patient alarms from data throughput degradation caused by non-clinical network traffic, visitor streaming, or large radiology file transfers occurring over adjacent network slices.

Infusion therapy and automated drug delivery systems are advancing rapidly through the integration of 5G cellular connectivity, automated cloud-based drug error reduction systems, and bi-directional electronic health record interoperability. Historical smart infusion pumps relied on intermittent, manual docking or unstable Wi-Fi links to update institutional drug libraries, resulting in months of lag time between hospital pharmacy formulary updates and physical device synchronization across massive hospital fleets. Contemporary 5G-connected volumetric and syringe infusion pumps maintain persistent, real-time cellular connections to centralized hospital pharmacy servers, downloading institutional drug dosing limits, continuous cybersecurity firmware patches, and patient-specific titration orders automatically, whether the pump is operating inside an intensive care unit, being moved between hospital wings, or functioning in a decentralized hospital-at-home environment. Integrated 5G telematics simultaneously stream granular infusion rate logs, remaining volume alerts, and downstream occlusion diagnostics to nursing dashboards, mitigating fatal dosing errors and eliminating manual infusion pump tracking.

Digital surgical visualization and interventional guidance represent another high-growth innovation frontier. Leading orthopedic, neurosurgical, and laparoscopy equipment manufacturers are embedding ultra-high-frequency millimeter-wave 5G modems into operating room imaging displays, surgical microscopes, and augmented reality headsets. Millimeter-wave 5G operating in the 24 GHz, 28 GHz, and 39 GHz spectrum bands delivers throughput exceeding 10 gigabits per second with air-interface latency under one millisecond, enabling the wireless transmission of uncompressed 4K and 8K stereoscopic 3D surgical video from intracorporeal endoscopic cameras to heads-up surgeon displays and remote proctoring stations without physical cabling across the sterile operating room floor. Surgeons utilizing 5G-connected augmented reality visors benefit from real-time digital overlays of patient CT vascular anatomy and pre-operative tumor boundaries mapped precisely onto the live operative field, transforming precision surgical execution and facilitating remote, real-time procedural collaboration between global surgical experts.

Continuous glucose monitoring and closed-loop automated insulin delivery systems are advancing through native 5G micro-transceivers that eliminate the requirement for companion consumer smartphones. Leading metabolic medtech innovators are developing self-contained continuous glucose sensors that communicate directly with cellular base stations via 5G narrow-band and RedCap protocols. By removing consumer smartphones from the continuous glycemic control loop, these devices eliminate clinical vulnerabilities associated with smartphone operating system updates, unapproved software app terminations, depleted consumer device batteries, and fragmented Bluetooth hardware connectivity. These autonomous 5G sensors transmit continuous interstitial glucose metrics, rate-of-change velocity arrows, and severe hypoglycemia predictive alerts directly to cloud-based clinical monitoring portals, pediatric parent dashboards, and automated emergency medical dispatch networks, ensuring uninterrupted clinical safety for pediatric, geriatric, and intellectually disabled diabetic patients.

Segmentation Insights

The U.S. 5G Connected Medical Devices Market is segmented on the basis of product category, connection architecture, clinical application, frequency band, end user, and geography.

By Product Category

The U.S. 5G Connected Medical Devices Market by product category is segmented into Remote Patient Monitoring and Wearable Biosensors, Connected Diagnostic and Point-of-Care Imaging Systems, Telemetry and Smart Critical Care Workstations, Smart Infusion Systems and Automated Drug Delivery Pumps, Digital Therapeutics, Surgical Assist and AR/VR Interventional Devices, and Embedded 5G Medical Gateways and Asset Telematics Hubs.

Remote Patient Monitoring and Wearable Biosensors
Remote patient monitoring and wearable biosensors represent the largest product category, accounting for USD 9.19 billion in 2026, following historical figures of USD 4.12 billion in 2023, USD 5.38 billion in 2024, and USD 7.03 billion in 2025. This category is projected to reach USD 31.78 billion by 2032, expanding at a CAGR of 22.97% from 2027 to 2032. Products within this domain encompass continuous wearable ECG patch sensors, 5G-enabled multi-parameter biometric rings and wristbands, continuous glucose monitoring sensors with integrated cellular basebands, smart pulse oximeters, cellular blood pressure cuffs, smart weight scales, and smart digital stethoscopes designed for domestic and ambulatory clinical surveillance.

The commercial leadership of this segment is anchored in the nationwide transition toward decentralized chronic disease management, value-based reimbursement frameworks, and the scaling of hospital-at-home clinical models. Health systems, physician organizations, and accountable care organizations are actively deploying continuous wearable biosensors to track high-risk cardiopulmonary and diabetic patients, leveraging CMS Remote Physiological Monitoring CPT codes to fund ongoing operations. Wearable 5G biosensors eliminate the friction of domestic Wi-Fi setup and smartphone Bluetooth pairing by establishing direct, secure cellular links to clinical dashboards the moment they are applied to the patient’s body. These devices stream continuous physiological trend data, enabling AI algorithms to identify sub-clinical deteriorations such as worsening fluid retention in congestive heart failure, nocturnal desaturations in chronic obstructive pulmonary disease, and asymptomatic atrial fibrillation, facilitating immediate pharmacological intervention that averts costly inpatient hospitalizations.

Connected Diagnostic and Point-of-Care Imaging Systems
Connected diagnostic and point-of-care imaging systems accounted for USD 5.46 billion in 2026, up from historical values of USD 2.52 billion in 2023, USD 3.26 billion in 2024, and USD 4.22 billion in 2025. This segment is projected to achieve USD 17.82 billion by 2032, demonstrating a CAGR of 21.79% from 2027 to 2032. Equipment in this category comprises handheld and mobile point-of-care ultrasound devices, 5G-connected digital radiography flat panels, mobile digital mammography units, mobile stroke unit CT scanners, digital dermatoscopes, connected fundus cameras, and 5G diagnostic video endoscopes.

Demand is fueled by the clinical imperative to execute immediate, definitive diagnostic evaluations at the patient’s bedside, within rural community clinics, and during pre-hospital emergency transport. 5G connectivity resolves the primary data bottleneck historically associated with portable medical imaging: the inability to transmit massive multi-gigabyte DICOM imaging files, raw cine-loops, and high-resolution volumetric cross-sectional scans over cellular networks without crippling transmission delays. With 5G enhanced mobile broadband, a full volumetric point-of-care ultrasound dataset or multi-slice mobile CT scan can be transmitted to a hospital picture archiving and communication system or a remote radiologist in under ten seconds. Furthermore, these imaging platforms leverage multi-access edge computing to run real-time AI algorithms that guide novice clinical operators in transducer positioning, automatically trace anatomical structures, and highlight suspected vascular occlusions or pulmonary consolidations.

Telemetry and Smart Critical Care Workstations
Telemetry and smart critical care workstations accounted for USD 3.98 billion in 2026, following historical revenues of USD 1.83 billion in 2023, USD 2.37 billion in 2024, and USD 3.07 billion in 2025. By 2032, the category is projected to reach USD 13.15 billion, advancing at a CAGR of 22.04% from 2027 to 2032. This segment encompasses modular bedside patient monitors, continuous multi-parameter telemetry transmitters, wireless critical care fetal monitors, transport vital signs monitors, centralized nursing surveillance workstations, and 5G-integrated emergency defibrillators tracking ECG, SpO2, invasive arterial pressures, capnography, and continuous cardiac output.

The primary catalyst driving this category is the hospital-wide deployment of enterprise private 5G networks designed to replace obsolete, interference-prone Wi-Fi telemetry networks. Intensive care units, step-down wards, and emergency departments require unbroken, deterministic wireless connections for high-acuity patients who are continuously mobile between treatment suites, radiology departments, and surgical wards. 5G telemetry transmitters utilize dedicated private cellular spectrum and automated network slicing, ensuring that life-critical arrhythmia alarms, continuous hemodynamic tracings, and respiratory curves maintain absolute priority over all other digital hospital traffic. This uninterrupted connectivity eliminates alarm fatigue caused by dropped wireless packets, ensures continuous EHR vitals documentation during patient transport, and enables centralized virtual nursing command centers to monitor high-acuity patient cohorts across sprawling hospital campuses.

Smart Infusion Systems and Automated Drug Delivery Pumps
Smart infusion systems and automated drug delivery pumps generated USD 2.74 billion in 2026, having grown from USD 1.26 billion in 2023, USD 1.63 billion in 2024, and USD 2.11 billion in 2025. This segment is on track to achieve USD 9.06 billion by 2032, exhibiting a CAGR of 22.06% from 2027 to 2032. This category comprises large-volume intravenous infusion pumps, ambulatory syringe pumps, patient-controlled analgesia devices, wearable continuous subcutaneous insulin infusion pumps, and smart elastomeric infusion systems.

The steady expansion of this domain is underpinned by patient safety initiatives, regulatory mandates surrounding drug library compliance, and the migration of complex chemotherapy and parenteral therapy into home healthcare settings. Smart infusion pumps equipped with native 5G modems maintain continuous bi-directional synchronization with hospital pharmacy management systems, enabling immediate, wireless deployment of updated drug error reduction system libraries across thousands of clinical devices without taking pumps out of clinical circulation. In outpatient oncology and home-based antibiotic therapy, 5G-connected ambulatory pumps continuously transmit real-time delivery metrics, flow-rate titrations, and downstream occlusion alerts to remote clinical pharmacists, preventing adverse drug events, detecting line occlusions instantly, and verifying that potent intravenous medications are administered in strict compliance with prescribed protocols.

Digital Therapeutics, Surgical Assist and AR/VR Interventional Devices
Digital therapeutics, surgical assist and AR/VR interventional devices accounted for USD 2.09 billion in 2026, up from historical levels of USD 0.92 billion in 2023, USD 1.21 billion in 2024, and USD 1.59 billion in 2025. The category is projected to reach USD 7.36 billion by 2032, growing at a CAGR of 23.35% from 2027 to 2032. Products include augmented reality surgical headsets, robotic-assisted surgical navigation consoles, virtual reality neuro-rehabilitation systems, 5G-connected wearable neurostimulators, biofeedback neuromodulation platforms, and tactile haptic feedback surgical consoles.

This represents the fastest-growing product category across the market, driven by the digital transformation of the operating room and the rapid adoption of immersive extended reality technologies in complex surgical interventions. Orthopedic, spine, and neurosurgeons increasingly utilize 5G-connected augmented reality visors to project holographic 3D patient anatomy, intraoperative CT reconstructions, and surgical trajectory guides directly onto their operative field of view. The millimeter-wave and sub-6 GHz 5G wireless infrastructure delivers the multi-gigabit throughput and sub-5-millisecond latency required to stream high-resolution stereoscopic spatial computing frames without causing motion sickness or visual lag for the operating surgeon. Furthermore, this category facilitates real-time remote surgical proctoring, allowing specialized surgical experts located hundreds of miles away to view live 3D surgical feeds and provide real-time interventional guidance via low-latency interactive telestration.

Embedded 5G Medical Gateways and Asset Telematics Hubs
Embedded 5G medical gateways and asset telematics hubs represented USD 1.72 billion in 2026, following historical figures of USD 0.80 billion in 2023, USD 1.03 billion in 2024, and USD 1.33 billion in 2025. The segment is projected to achieve USD 5.55 billion by 2032, demonstrating a CAGR of 21.56% from 2027 to 2032. This infrastructure category encompasses multi-protocol medical translation gateways, ruggedized connected ambulance gateways, in-home multi-sensor cellular aggregation hubs, real-time location system telematics beacons, and secure enterprise hospital IoT communication appliances.

The essential role of this category lies in bridging legacy medical hardware and diverse medical communication protocols into unified, secure 5G cellular pipelines. In domestic hospital-at-home environments, a dedicated 5G medical gateway aggregates data from multiple short-range Bluetooth, Zigbee, or NFC peripherals—such as spirometers, glucometers, and weight scales—and securely tunnels encrypted medical data packets across public cellular networks to hospital servers, eliminating the technical friction of managing multiple individual cellular subscriptions. In institutional acute care environments, 5G asset tracking hubs and telematics beacons provide high-precision real-time location tracking of mobile medical equipment, including crash carts, ventilators, and infusion pumps, dramatically reducing equipment search times for clinical staff, optimizing fleet maintenance schedules, and mitigating costly capital equipment loss across multi-building healthcare facilities.

By Connection Architecture

The U.S. 5G Connected Medical Devices Market by connection architecture is segmented into Dedicated Private 5G Cellular Networks, Public 5G Cellular Networks, and Hybrid and Sliced 5G Healthcare Architectures.

Dedicated Private 5G Cellular Networks
Dedicated private 5G cellular networks represent a premier capital expenditure architecture, accounting for USD 10.07 billion in 2026, up from historical values of USD 4.47 billion in 2023, USD 5.86 billion in 2024, and USD 7.68 billion in 2025. This segment is projected to reach USD 34.74 billion by 2032, expanding at a CAGR of 22.92% from 2027 to 2032. This architecture comprises on-premise private 5G radio access networks, localized 5G core network appliances, dedicated small cells, distributed antenna systems, and local Multi-Access Edge Computing servers deployed exclusively within hospital campuses, academic medical complexes, and specialized surgical facilities.

The dominant growth of private 5G cellular infrastructure within acute healthcare facilities is fueled by the stringent security, reliability, and deterministic latency requirements of enterprise health systems. Private 5G networks operate primarily on Citizens Broadband Radio Service OnGo shared spectrum between 3.55 GHz and 3.70 GHz, alongside leased mid-band spectrum, establishing a radio environment completely isolated from external public telecommunications traffic and local consumer device congestion. Hospital Chief Information Officers and biomedical engineering directors favor private 5G networks because all patient physiological data, biometric telemetry, and clinical imaging files remain entirely on-premise behind institutional firewalls, satisfying rigorous HIPAA compliance and zero-trust cybersecurity mandates. Furthermore, private 5G delivers deterministic quality of service, automated microsecond-level synchronization, and consistent indoor radio coverage that penetrates reinforced concrete, lead-lined radiology suites, and subterranean surgical complexes where conventional Wi-Fi networks suffer severe dead zones.

Public 5G Cellular Networks
Public 5G cellular networks accounted for USD 10.15 billion in 2026, following historical revenues of USD 4.69 billion in 2023, USD 6.06 billion in 2024, and USD 7.84 billion in 2025. By 2032, the category is projected to reach USD 33.04 billion, growing at a CAGR of 21.74% from 2027 to 2032. This architecture leverages the extensive nationwide macro-cellular infrastructure deployed by tier-one telecommunications carriers, utilizing low-band and mid-band public 5G frequencies to provide continuous wide-area cellular connectivity for outpatient and mobile medical hardware.

Public cellular connectivity represents the foundational architectural backbone for remote patient monitoring, ambulatory chronic disease management, mobile integrated healthcare, and domestic hospital-at-home programs. The extensive geographic footprint and high population coverage of public 5G networks enable medical device manufacturers to distribute pre-configured, self-activating medical devices to patients across urban, suburban, and rural settings without requiring local technical installation. Public 5G networks leverage massive machine-type communications protocols that support millions of concurrent, low-bandwidth medical sensor endpoints per macro cell site, ensuring that continuous glucose monitors, smart asthma inhalers, and cardiac rhythm patches maintain persistent cellular connections while patients travel, commute, and carry out daily activities, establishing continuous outpatient surveillance lifelines.

Hybrid and Sliced 5G Healthcare Architectures
Hybrid and sliced 5G healthcare architectures represented USD 4.96 billion in 2026, having grown from USD 2.29 billion in 2023, USD 2.96 billion in 2024, and USD 3.83 billion in 2025. The segment is on track to achieve USD 16.94 billion by 2032, advancing at a CAGR of 22.72% from 2027 to 2032. This domain encompasses end-to-end network slicing deployments across public carrier infrastructure, hybrid cloud-edge cellular integration, carrier-managed private network slices, and dynamic multi-operator core networks that bridge on-premise hospital private RANs with nationwide public cellular coverage.

This architecture is expanding rapidly as healthcare systems seek the enterprise control of private networks combined with the wide-area mobility of public cellular infrastructure. Dynamic 5G network slicing enables telecommunications operators to provision dedicated, software-defined virtual networks over shared physical infrastructure, guaranteeing specific bandwidth, latency, and security parameters tailored to medical applications. For example, a hospital system can procure an enterprise network slice that guarantees sub-10-millisecond latency and continuous cryptographic isolation for its emergency ambulance fleet and outpatient hospital-at-home patients across an entire metropolitan area. Medical devices connected to this sliced architecture seamlessly transition between hospital campus private 5G small cells and the external public carrier network slice without dropping active data sessions, providing unbroken, end-to-end quality of service for continuous biometric monitoring and mobile telemedicine.

By Clinical Application

The U.S. 5G Connected Medical Devices Market by clinical application is segmented into Chronic Disease Management and Ambulatory Monitoring, Emergency Medical Services and Connected Ambulance Resuscitation, In-Hospital Critical Care, Surgical Navigation and Tele-Robotics, Digital Pathology and High-Bandwidth Teleradiology, and Post-Acute Rehabilitation and Home Health Optimization.

Chronic Disease Management and Ambulatory Monitoring
Chronic disease management and ambulatory monitoring represents the premier clinical application, accounting for USD 9.47 billion in 2026, up from historical levels of USD 4.24 billion in 2023, USD 5.54 billion in 2024, and USD 7.24 billion in 2025. The segment is projected to achieve USD 32.45 billion by 2032, expanding at a CAGR of 22.78% from 2027 to 2032. Clinical indications include congestive heart failure, type 1 and type 2 diabetes, chronic obstructive pulmonary disease, hypertension, chronic kidney disease, and cardiac arrhythmias managed across outpatient and domestic settings.

The overwhelming revenue leadership of this segment is driven by the vast demographic burden of chronic illness in the United States and the strong financial incentives for health systems to manage these populations outside high-cost inpatient environments. Continuous ambulatory monitoring utilizing 5G-connected continuous glucose monitors, cellular blood pressure cuffs, smart weight scales, and wearable ECG patches provides clinical care teams with real-time visibility into disease trajectory. The persistent, high-frequency data streams generated by 5G medical devices feed directly into automated population health analytics engines that identify acute warning signs, such as rapid weight gain indicating pulmonary edema or erratic glycemic excursions, triggering proactive pharmacological titrations by clinical pharmacists or virtual nurse navigators. This continuous intervention model minimizes acute exacerbations, enhances patient therapeutic adherence, and dramatically lowers the incidence of emergency department visits.

Emergency Medical Services and Connected Ambulance Resuscitation
Emergency medical services and connected ambulance resuscitation accounted for USD 5.21 billion in 2026, following historical figures of USD 2.40 billion in 2023, USD 3.11 billion in 2024, and USD 4.03 billion in 2025. The category is projected to reach USD 17.11 billion by 2032, demonstrating a CAGR of 21.92% from 2027 to 2032. Applications encompass pre-hospital triage, mobile stroke unit neuroimaging transmission, real-time 12-lead ECG telemetry for ST-elevation myocardial infarction, trauma ultrasound streaming, paramedic video tele-consultation, and automated emergency vehicle telematics.

The rapid modernization of emergency medical services is anchored in the clinical reality that pre-hospital treatment velocity directly dictates patient survival and neurological recovery in acute cardiovascular, neurological, and trauma emergencies. Equipping emergency ambulances with high-bandwidth 5G multi-network vehicular routers and connected diagnostic hardware transforms the emergency vehicle into a mobile hospital emergency bay. Paramedics perform point-of-care ultrasound examinations, capture multi-lead ECGs, and execute mobile CT scans while streaming uncompressed video and diagnostic telemetry directly to attending hospital emergency physicians in real time. This ultra-low-latency connectivity enables emergency physicians to confirm diagnoses, direct advanced pre-hospital pharmacological interventions, and activate hospital cardiac catheterization suites or surgical trauma teams well before the ambulance physically reaches the emergency department ramp.

In-Hospital Critical Care, Surgical Navigation and Tele-Robotics
In-hospital critical care, surgical navigation and tele-robotics generated USD 4.46 billion in 2026, up from historical values of USD 2.06 billion in 2023, USD 2.66 billion in 2024, and USD 3.44 billion in 2025. The segment is on track to achieve USD 14.83 billion by 2032, advancing at a CAGR of 22.17% from 2027 to 2032. Applications include intensive care unit continuous multi-parameter telemetry, augmented reality intraoperative navigation, robotic-assisted surgical console communication, real-time endoscopic surgical video distribution, and tele-robotic procedural proctoring.

Within the surgical suite and critical care wards, 5G wireless infrastructure resolves physical operational bottlenecks and elevates procedural precision. In contemporary operating rooms, traditional physical cabling connecting surgical camera heads, endoscopic towers, fluoroscopy units, and surgical displays creates severe physical clutter, sterility maintenance challenges, and tripping hazards. Millimeter-wave and private sub-6 GHz 5G transceivers embedded in surgical displays and robotic arms allow wireless transmission of uncompressed 4K and 8K stereoscopic surgical video with latencies below 5 milliseconds, preserving critical hand-eye coordination for laparoscopic and robotic surgeons. Furthermore, in intensive care units, private 5G telemetry workstations stream continuous hemodynamic waveforms to centralized virtual ICU monitoring pods, enabling remote intensivist physicians to oversee critical care management across multiple hospitals simultaneously.

Digital Pathology and High-Bandwidth Teleradiology
Digital pathology and high-bandwidth teleradiology represented USD 3.45 billion in 2026, having expanded from USD 1.60 billion in 2023, USD 2.07 billion in 2024, and USD 2.67 billion in 2025. By 2032, the segment is projected to reach USD 11.35 billion, exhibiting a CAGR of 21.95% from 2027 to 2032. This domain comprises ultra-high-resolution whole-slide imaging transmission, frozen section tele-pathology, mobile digital radiography streaming, high-volume CT and MRI PACS synchronization, and cloud-edge teleradiology consultations.

The primary catalyst for this application is the acute clinical shortage of sub-specialty radiologists and board-certified pathologists across community and regional hospital networks. A single whole-slide digital pathology scan or multi-slice volumetric CT dataset frequently ranges from 500 megabytes to multiple gigabytes in size. Legacy broadband and wireless connections struggle to transmit these massive data files rapidly, creating diagnostic bottlenecks that delay intraoperative decision-making and patient discharge workflows. 5G enhanced mobile broadband provides the gigabit-tier uplink and downlink throughput necessary to transmit massive pathology slide scans and volumetric radiology studies in seconds, enabling pathologists and radiologists to review high-fidelity diagnostic images from centralized reading hubs or decentralized home workstations without loss of diagnostic resolution or clinical workflow latency.

Post-Acute Rehabilitation and Home Health Optimization
Post-acute rehabilitation and home health optimization accounted for USD 2.59 billion in 2026, following historical levels of USD 1.15 billion in 2023, USD 1.50 billion in 2024, and USD 1.97 billion in 2025. The category is projected to reach USD 8.98 billion by 2032, growing at a CAGR of 23.03% from 2027 to 2032. Applications include virtual reality motor neuro-rehabilitation, connected smart orthopedic braces and joint range-of-motion monitors, cellular smart fall-detection systems, continuous wound care imaging monitors, and automated post-surgical recovery tracking.

This application is expanding rapidly as health systems and post-acute care providers seek to shorten costly skilled nursing facility stays and optimize physical recovery in the patient’s home. 5G-connected wearable orthopedic sensors and smart braces track joint biomechanics, angular velocity, and weight-bearing progress following total knee or hip arthroplasty, streaming kinematic data directly to physical therapy dashboards. Virtual reality rehabilitation platforms leverage ultra-low-latency 5G connections to deliver interactive, gamified neuro-rehabilitation exercises for stroke survivors, adjusting physical resistance and task difficulty in real time based on patient kinematic responses. This continuous, objective data capture ensures patient therapeutic compliance, enables remote clinicians to adjust rehabilitation regimens proactively, and lowers the incidence of post-operative complications and joint stiffness.

By Frequency Band

The U.S. 5G Connected Medical Devices Market by frequency band is segmented into Sub-6 GHz Mid-Band, Low-Band 5G, and Millimeter Wave.

Sub-6 GHz Mid-Band
Sub-6 GHz mid-band represents the dominant and most versatile frequency tier, accounting for USD 14.25 billion in 2026, up from USD 6.41 billion in 2023, USD 8.36 billion in 2024, and USD 10.91 billion in 2025. The category is projected to reach USD 48.29 billion by 2032, advancing at a CAGR of 22.56% from 2027 to 2032. This frequency domain encompasses mid-band carrier frequencies between 2.5 GHz and 3.98 GHz, including the Citizens Broadband Radio Service band (3.55–3.70 GHz) and commercial C-Band spectrum (3.70–3.98 GHz).

The market dominance of mid-band spectrum stems from its optimal physical balance between high data throughput, robust signal propagation, and superior indoor structural penetration. Enterprise private 5G hospital networks are predominantly constructed within the CBRS and C-band frequencies, providing healthcare facilities with clean, dedicated spectrum that penetrates dense hospital construction materials, including leaded radiology walls, concrete support shafts, and modular surgical suites. Mid-band 5G delivers data transfer rates ranging from 100 megabits per second to over 1 gigabit per second with latencies below 10 milliseconds, making it the ideal connectivity medium for high-density medical device deployments, continuous multi-channel bedside telemetry, point-of-care ultrasound streaming, and automated hospital smart pump fleets operating across complex multi-floor hospital campuses.

Low-Band 5G
Low-band 5G accounted for USD 6.90 billion in 2026, following historical figures of USD 3.21 billion in 2023, USD 4.14 billion in 2024, and USD 5.34 billion in 2025. By 2032, the category is projected to reach USD 22.45 billion, reflecting a CAGR of 21.73% from 2027 to 2032. This frequency band operates on spectrum below 1 GHz, primarily utilizing the 600 MHz, 700 MHz, 800 MHz, and 850 MHz cellular bands deployed across commercial telecommunications carrier macro networks.

Low-band 5G represents the foundational connectivity tier for wide-area remote patient monitoring, ambulatory biosensors, and rural healthcare delivery. While low-band frequencies provide lower peak data speeds than mid-band or millimeter-wave spectrum, they deliver unmatched geographical coverage range and exceptional building penetration capabilities. A low-band 5G signal can travel tens of miles from a macro cell tower and easily penetrate exterior residential walls, subterranean basements, and rural structures where higher-frequency signals attenuate rapidly. Consequently, medical device manufacturers embedding cellular modems into continuous glucose monitors, smart weight scales, cellular blood pressure cuffs, and wearable asthma monitors rely heavily on low-band 5G to ensure that chronically ill patients maintain continuous, uninterrupted cellular connectivity regardless of geographic location or domestic building construction.

Millimeter Wave
Millimeter wave accounted for USD 4.03 billion in 2026, having grown from USD 1.83 billion in 2023, USD 2.38 billion in 2024, and USD 3.10 billion in 2025. The segment is on track to achieve USD 13.98 billion by 2032, exhibiting a CAGR of 23.04% from 2027 to 2032. This high-frequency tier operates within the extreme high-frequency spectrum between 24 GHz and 40 GHz, utilizing massive multi-input multi-output antenna arrays and advanced beamforming architectures.

Millimeter-wave 5G represents an ultra-high-performance, specialized connectivity domain engineered for data-intensive, latency-intolerant clinical applications concentrated within defined physical spaces. Operating at frequencies of 24 GHz, 28 GHz, and 39 GHz, mmWave systems deliver multi-gigabit per second data transfer speeds and air-interface latencies below 1 millisecond. Within modern surgical suites, hybrid catheterization laboratories, and academic imaging research centers, mmWave small cells enable the uncompressed wireless transmission of ultra-high-definition 4K and 8K surgical video, real-time holographic augmented reality rendering, and multi-gigabyte intraoperative CT datasets. While mmWave signals suffer from limited propagation range and cannot penetrate human tissue or physical walls effectively, their extreme bandwidth and deterministic latency make them indispensable for wireless surgical consoles and immersive interventional guidance systems where physical cabling poses severe clinical hazards.

By End User

The U.S. 5G Connected Medical Devices Market by end user is segmented into Integrated Delivery Networks and Health Systems, Outpatient Ambulatory Surgical Centers and Specialty Clinics, Emergency Medical Services and Trauma Response Systems, Academic Medical Centers and Clinical Research Institutes, and Home Healthcare Agencies and Virtual Care Providers.

Integrated Delivery Networks and Health Systems
Integrated delivery networks and health systems represent the largest commercial end-user category, accounting for USD 11.73 billion in 2026, up from historical values of USD 5.27 billion in 2023, USD 6.87 billion in 2024, and USD 8.98 billion in 2025. The segment is projected to reach USD 40.16 billion by 2032, expanding at a CAGR of 22.77% from 2027 to 2032. This segment encompasses major non-profit and investor-owned health systems, multi-hospital hospital networks, regional integrated healthcare delivery systems, and Veterans Health Administration medical centers.

Integrated delivery networks command the premier commercial position due to their massive capital expenditure budgets, centralized procurement frameworks, extensive multi-hospital physical infrastructure, and heavy financial exposure to value-based risk contracts. IDNs execute enterprise-wide procurement agreements to deploy private 5G cellular infrastructure across entire hospital campuses, standardizing fleets of thousands of 5G-enabled smart infusion pumps, bedside patient monitors, and mobile telemetry transmitters. These large healthcare organizations leverage 5G connectivity to streamline clinical workflows, reduce costly nurse charting hours, deploy centralized virtual nursing and telemetry command centers, and maintain continuous clinical surveillance over high-acuity patients transitioning from physical inpatient beds to hospital-at-home virtual wards, maximizing operational efficiency and minimizing CMS readmission financial penalties.

Outpatient Ambulatory Surgical Centers and Specialty Clinics
Outpatient ambulatory surgical centers and specialty clinics accounted for USD 5.46 billion in 2026, following historical revenues of USD 2.52 billion in 2023, USD 3.26 billion in 2024, and USD 4.22 billion in 2025. The category is projected to reach USD 18.04 billion by 2032, demonstrating a CAGR of 22.04% from 2027 to 2032. Facilities include freestanding surgical centers, outpatient orthopedic clinics, specialized cardiology practices, ambulatory cancer treatment centers, and multi-specialty physician practices.

The rapid growth of this end-user segment is propelled by the structural migration of surgical procedures—including total joint replacements, spinal decompressions, and cardiac catheterizations—from high-cost hospital inpatient operating rooms to lower-cost outpatient ambulatory surgical centers. ASCs operate with lean clinical staffing and tight turnover schedules between surgical cases, creating high demand for wireless, lightweight, 5G-connected medical hardware. Outpatient surgical centers invest heavily in 5G-connected point-of-care ultrasound, wireless surgical displays, augmented reality navigation visors, and rapid-turnaround digital diagnostic tools that eliminate cumbersome physical cabling, accelerate operating room turnover times, and ensure seamless cloud-based electronic health record documentation without requiring extensive internal IT infrastructure.

Emergency Medical Services and Trauma Response Systems
Emergency medical services and trauma response systems accounted for USD 3.25 billion in 2026, up from historical levels of USD 1.49 billion in 2023, USD 1.93 billion in 2024, and USD 2.50 billion in 2025. The segment is on track to achieve USD 10.76 billion by 2032, advancing at a CAGR of 22.08% from 2027 to 2032. This group comprises municipal fire and rescue departments, private emergency ambulance operators, hospital-based mobile critical care transport services, and air medical helicopter evacuation programs.

EMS authorities and trauma networks represent high-urgency purchasers of ruggedized, mission-critical 5G medical hardware. Emergency response organizations are modernizing their fleets by deploying ruggedized 5G mobile gateways, connected 12-lead defibrillators, portable blood analyzers, and mobile CT scanners inside emergency vehicles. Paramedics and flight nurses operate in extreme, unpredictable field conditions where seconds determine clinical survival. The ability to stream continuous, multi-parameter vital signs, high-definition tele-consultation video, and full diagnostic imaging scans to receiving trauma surgeons while traveling at highway speeds enables emergency departments to mobilize operating rooms, clear CT suites, and assemble trauma teams before the emergency transport vehicle arrives, fundamentally transforming survival outcomes in severe trauma and stroke care.

Academic Medical Centers and Clinical Research Institutes
Academic medical centers and clinical research institutes generated USD 2.74 billion in 2026, having grown from USD 1.26 billion in 2023, USD 1.63 billion in 2024, and USD 2.11 billion in 2025. The segment is projected to achieve USD 9.07 billion by 2032, exhibiting a CAGR of 22.08% from 2027 to 2032. This segment includes university-affiliated tertiary teaching hospitals, medical research foundations, and major biomedical clinical trial institutes.

Academic medical centers serve as the premier proving ground and early-adoption testing environment for state-of-the-art 5G medical device innovations. Supported by federal research grants, extensive private endowments, and academic medtech partnerships, these institutions possess the financial liquidity and clinical engineering expertise required to deploy complex, bleeding-edge technologies. Academic teaching hospitals are the primary adopters of 5G-connected robotic surgical navigation systems, millimeter-wave intraoperative augmented reality platforms, digital pathology whole-slide transmission networks, and experimental tele-robotic surgical consoles. Device vendors collaborate closely with academic medical centers to conduct rigorous clinical efficacy trials, generate peer-reviewed data, and establish the clinical safety and workflow protocols that govern broader commercial adoption across the healthcare industry.

Home Healthcare Agencies and Virtual Care Providers
Home healthcare agencies and virtual care providers accounted for USD 2.00 billion in 2026, following historical figures of USD 0.91 billion in 2023, USD 1.19 billion in 2024, and USD 1.54 billion in 2025. By 2032, the category is projected to reach USD 6.69 billion, expanding at a CAGR of 22.29% from 2027 to 2032. This segment comprises licensed home health nursing agencies, virtual medical practice platforms, specialized remote monitoring management companies, and post-acute hospice organizations.

The rapid expansion of this end-user classification reflects the exponential growth of virtual clinical care delivery and consumer preference for domestic healthcare management. Home healthcare agencies and virtual care companies manage vast, geographically dispersed patient panels suffering from chronic complex diseases. These providers procure large volumes of cellular-connected medical hardware, including 5G wearable biosensors, connected pulse oximeters, smart medication dispensers, and cellular blood pressure cuffs that require zero technical expertise from the patient. Virtual care platforms integrate these continuous 5G data feeds into proprietary clinical dashboards, utilizing centralized nurse triage teams to deliver high-touch clinical oversight, manage medication titrations remotely, and coordinate timely in-person clinical home visits when biometric indicators signal impending clinical decompensation.

Regional Insights: Where the Market is Growing Fastest

The U.S. 5G Connected Medical Devices Market is geographically segmented into four primary commercial regions: the South, the West, the Midwest, and the Northeast. Regional market performance is governed by underlying structural dynamics, including demographic population density, chronic disease prevalence, integrated delivery network consolidation velocity, state-level broadband and private 5G infrastructure investments, municipal emergency medical services modernization budgets, the concentration of prestigious academic medical centers, and regional health insurance payer mix.

South

The South represents the largest commercial regional market for 5G connected medical devices in the United States, generating USD 9.16 billion in 2026, up from historical levels of USD 4.12 billion in 2023, USD 5.38 billion in 2024, and USD 7.02 billion in 2025. The Southern regional market is projected to reach USD 31.09 billion by 2032, expanding at a CAGR of 22.59% from 2027 to 2032. The South’s market leadership is driven by massive population in-migration, the highest regional concentration of chronic cardiovascular, metabolic, and respiratory disease in the nation, expansive rural geographies requiring remote healthcare lifelines, and progressive investments in enterprise private 5G network infrastructure across major commercial hospital networks. Furthermore, the region encompasses major corporate healthcare conglomerates and expansive municipal trauma networks that are systematically upgrading legacy hospital Wi-Fi networks to dedicated cellular infrastructure.

Texas represents the dominant economic engine within the Southern 5G connected medical devices landscape, supported by over 30 million residents, vast rural expanses, and premier medical centers. The Texas Medical Center in Houston, recognized as the largest medical complex in the world, alongside expansive integrated delivery networks including Baylor Scott & White Health, Memorial Hermann, and Texas Health Resources, represent aggressive institutional buyers of enterprise 5G private cellular networks and connected clinical hardware. In major metropolitan centers such as Houston, Dallas-Fort Worth, Austin, and San Antonio, hospital systems have deployed dedicated private 5G CBRS infrastructure across inpatient towers, surgical suites, and intensive care units. These private cellular networks support thousands of 5G-connected smart infusion pumps, mobile patient telemetry transmitters, and automated asset-tracking telematics hubs. Concurrently, the sprawling geographic footprint of West and South Texas, characterized by vast distances between rural community hospitals and urban tertiary trauma centers, has driven extensive procurement of 5G-connected emergency ambulances, mobile stroke units, and remote patient monitoring kits. Rural healthcare providers across Texas actively deploy continuous 5G wearable biosensors and cellular continuous glucose monitors to manage high incidences of diabetes and hypertension, bridging critical clinical access gaps and reducing emergency medical transfers to urban medical hubs.

Florida represents the second-largest state market within the South, distinguished by an exceptionally large geriatric demographic, high rates of chronic cardiopulmonary disease, and extensive private health system consolidation. Major integrated delivery networks including AdventHealth, Baptist Health South Florida, Tampa General Hospital, and the Mayo Clinic campus in Jacksonville are leading the state’s connected healthcare deployment. Florida’s high population of retirees aged 65 and older creates an immense clinical demand pool for remote patient monitoring, continuous ambulatory cardiac rhythm tracking, and home-based continuous biometric surveillance. Health systems across major metropolitan corridors, including Miami-Fort Lauderdale, Tampa-St. Petersburg, and Orlando, have heavily commercialized hospital-at-home programs. These virtual acute care programs deploy 5G-connected wearable multi-parameter patches, cellular blood pressure monitors, and continuous pulse oximeters to safely manage elderly patients recovering from heart failure exacerbations, pneumonia, and total joint arthroplasty in their personal residences. Furthermore, municipal emergency medical service departments across South Florida have modernized their vehicle fleets with high-bandwidth 5G vehicular gateways, enabling continuous transmission of high-definition pre-hospital tele-consultations, 12-lead ECGs, and ultrasound cine-loops to receiving emergency departments, significantly reducing door-to-balloon times for acute myocardial infarction patients.

North Carolina and Georgia represent rapidly expanding 5G medical device hubs propelled by booming technology corridors, prestigious academic medical institutions, and aggressive investments in rural broadband and cellular infrastructure. In North Carolina, the Research Triangle region, encompassing Raleigh, Durham, and Chapel Hill, serves as a premier national testbed for 5G medical device engineering and digital health commercialization. Duke University Health System, UNC Health, and Atrium Health have executed extensive clinical deployments of private 5G networks, testing 5G-connected augmented reality surgical navigation platforms and edge-AI diagnostic ultrasound devices. In rural eastern and western North Carolina, health systems partner with regional telecommunications providers to distribute 5G-enabled cellular medical gateways to manage chronic heart failure and diabetic populations residing in mountainous or agricultural communities lacking broadband infrastructure. Georgia, anchored by the massive Atlanta metropolitan region and healthcare giants such as Emory Healthcare and Piedmont Healthcare, demonstrates heavy capital investments in 5G-connected emergency response networks and virtual nursing platforms. Grady Memorial Hospital, home to Atlanta’s premier Level 1 trauma center, utilizes high-bandwidth 5G mobile connections to support connected ambulance pre-hospital triage and emergency trauma coordination.

Tennessee, Virginia, and the broader Gulf Coast states—including Louisiana, Alabama, and Mississippi—sustain substantial and expanding demand across both acute hospital and decentralized ambulatory 5G medical device categories. Tennessee represents the corporate management hub of the American commercial healthcare provider sector, hosting the headquarters of major national hospital management corporations, including HCA Healthcare and Community Health Systems in Nashville. These corporate healthcare operators execute centralized procurement agreements for hundreds of affiliated hospitals across the nation, establishing standardized enterprise specifications for 5G-enabled patient monitors, smart beds, and pharmacy infusion systems. In Virginia, the high-density, technology-forward northern Virginia corridor alongside the VCU Health system in Richmond exhibits rapid adoption of 5G digital pathology platforms and outpatient remote patient monitoring suites. Across the rural expanses of Alabama, Mississippi, and Louisiana, which face the highest rates of cardiovascular disease, stroke mortality, and maternal morbidity in the United States, federally qualified health centers and state health departments are deploying 5G-connected maternal and fetal monitors, continuous cardiac telemetry patches, and cellular point-of-care diagnostic kiosks to provide continuous clinical oversight in medically underserved communities.

The commercial landscape across the South is characterized by the strategic necessity to bridge stark healthcare delivery disparities between hyper-dense, corporate-consolidated urban medical complexes and under-resourced rural hospital networks. Device manufacturers that offer versatile 5G connected medical platforms that operate seamlessly on both on-premise private 5G CBRS hospital networks and wide-area public carrier networks capture decisive competitive advantages across this vast, rapidly growing regional healthcare market.

West

The West represents the fastest-growing 5G connected medical devices region through 2032, accounting for USD 7.18 billion in 2026, following historical revenues of USD 3.21 billion in 2023, USD 4.19 billion in 2024, and USD 5.49 billion in 2025. The Western market is projected to reach USD 24.57 billion by 2032, demonstrating a CAGR of 22.76% from 2027 to 2032. The region’s exceptional market trajectory is propelled by early and aggressive clinical technology adoption, nation-leading venture capital and private equity investment in digital health, extensive coverage of advanced private 5G networks across urban healthcare corridors, and progressive state-level policies that incentivize remote patient monitoring, virtual care delivery, and artificial intelligence-assisted clinical diagnostics.

California represents the undisputed commercial anchor of the Western region and the single largest individual state market for 5G connected medical devices in the United States. Supported by a population exceeding 38 million residents, California’s healthcare landscape is defined by world-renowned academic medical centers, massive integrated managed care delivery networks, and concentrated digital health venture capital. Giants such as Kaiser Permanente, Sutter Health, Cedars-Sinai Medical Center, Stanford Health Care, and the expansive University of California Health system are national benchmarks in connected healthcare modernization. Healthcare providers across the San Francisco Bay Area, Silicon Valley, the Greater Los Angeles basin, and San Diego have aggressively deployed private 5G networks and multi-access edge computing infrastructure across their acute hospital facilities. In these leading medical centers, 5G networks support high-definition robotic surgical tele-proctoring, real-time wireless 4K endoscopic video streaming, and campus-wide virtual nursing command centers that remotely manage inpatient acuity. Concurrently, California’s progressive Medi-Cal reimbursement policies and commercial payer landscape have accelerated the distribution of hundreds of thousands of 5G-connected continuous glucose monitors, wearable arrhythmia patches, and cellular smart blood pressure monitors across diverse patient demographics, driving massive outpatient device utilization.

Washington and Oregon represent mature, highly innovative connected health markets characterized by advanced institutional healthcare infrastructure, forward-thinking medical technology policies, and dense urban technology hubs. In Washington, the Seattle metropolitan region serves as a global nexus for cloud computing, telecommunications, and biomedical innovation, hosting major operations for telecommunications giants, cloud hyperscalers, and leading health systems, including Providence Health & Services and UW Medicine. Providence has pioneered enterprise-wide deployments of 5G-connected smart hospital rooms and automated hospital-at-home networks across the Pacific Northwest, deploying thousands of 5G biometric sensors to monitor post-surgical and chronic care patients remotely. In Oregon, major health systems such as Oregon Health & Science University and Legacy Health have integrated 5G-enabled point-of-care diagnostic imaging systems and connected emergency ambulance fleets to manage emergency trauma and stroke triage across both the densely populated Willamette Valley and expansive, geographically isolated coastal and rural logging communities.

Colorado, Arizona, and Utah represent high-growth interior Western markets fueled by substantial population growth, expanding regional technology economies, and progressive healthcare delivery frameworks. In Colorado, the Front Range urban corridor—spanning Fort Collins, Denver, and Colorado Springs—features prominent health systems such as UCHealth and Centura Health that have deployed high-speed private 5G networks to support high-acuity surgical suites, automated medication infusion fleets, and regional tele-ICU networks that monitor critical care patients across the Rocky Mountain region. Arizona, anchored by the sprawling Phoenix and Tucson metropolitan regions, features major healthcare institutions including Banner Health, HonorHealth, and the Mayo Clinic campus in Phoenix. Arizona’s expanding retiree population has created a massive, year-round commercial market for 5G-connected remote patient monitoring systems, continuous cardiac rhythm telemetry, and cellular fall-detection platforms. In Utah, the Intermountain Health system, globally recognized for its operational efficiency and evidence-based clinical protocols, has established enterprise virtual hospital programs that deploy thousands of 5G-connected diagnostic and therapeutic medical devices across hospital-at-home, outpatient post-surgical, and chronic pulmonary patient cohorts throughout the Intermountain West.

The broader Mountain and Western states—including Nevada, Idaho, Montana, Wyoming, and New Mexico—exhibit specialized, high-growth procurement dynamics centered on overcoming extreme geographic isolation and rural healthcare provider shortages. Major healthcare facilities in Las Vegas, Reno, Boise, and Albuquerque serve as tertiary referral hubs for vast geographical territories. These health systems invest heavily in 5G-connected mobile stroke ambulances, mobile digital mammography vans, and ruggedized 5G emergency medical gateways that allow rural emergency personnel, tribal health clinics, and critical access hospitals to transmit diagnostic ultrasound cine-loops, 12-lead ECGs, and high-resolution radiographic imaging to urban tertiary specialists for immediate, real-time clinical consultation.

The commercial environment in the West is characterized by high expectations for seamless cloud software integration, sophisticated artificial intelligence capability, zero-trust cryptographic security, and human-centered ergonomic device design. Healthcare providers across the West rapidly decommission legacy, siloed medical hardware in favor of agile, multi-functional 5G connected systems that integrate natively with enterprise cloud platforms and provide continuous, actionable clinical intelligence.

Midwest

The Midwest represents a mature, highly resilient, and clinically sophisticated market for 5G connected medical devices, generating USD 5.19 billion in 2026, up from historical levels of USD 2.40 billion in 2023, USD 3.10 billion in 2024, and USD 4.01 billion in 2025. The Midwestern market is projected to reach USD 17.11 billion by 2032, expanding at a CAGR of 22.00% from 2027 to 2032. The region’s commercial strength is rooted in its dense concentration of world-renowned academic medical centers, expansive integrated delivery networks, high prevalence of chronic metabolic and cardiopulmonary conditions across industrial and agricultural populations, and disciplined, value-oriented capital procurement strategies that demand proven clinical return on investment.

Illinois and Ohio serve as the primary economic and clinical pillars of the Midwestern 5G connected medical devices landscape. In Illinois, the Chicago metropolitan area encompasses one of the densest and most lucrative healthcare markets in the nation, featuring prominent health systems including Northwestern Medicine, Rush University System for Health, Advocate Health, and the University of Chicago Medicine. Chicago-area hospitals have invested aggressively in private 5G cellular infrastructure to modernize their inpatient facilities, eliminating Wi-Fi interference across multi-tower urban hospital campuses and deploying enterprise fleets of 5G-enabled smart infusion pumps, transport vital signs monitors, and digital mobile X-ray detectors. In Ohio, the healthcare sector is anchored by the world-famous Cleveland Clinic health system and The Ohio State University Wexner Medical Center in Columbus. Cleveland Clinic has been an early national pioneer in implementing private 5G hospital networks, leveraging ultra-low-latency 5G wireless connections to transmit uncompressed surgical video in robotic operating rooms, pilot 5G-enabled robotic disinfection systems, and operate continuous remote monitoring command centers that track thousands of inpatient and domestic chronic care patients across northern Ohio.

Michigan, Indiana, and Wisconsin provide substantial dual-sector market demand spanning massive urban health systems, suburban hospital networks, and expansive rural critical access facilities. In Michigan, the healthcare landscape, centered on Detroit, Ann Arbor, and Grand Rapids, is led by Corewell Health, the University of Michigan Health, and Henry Ford Health. These systems have scaled comprehensive virtual care programs that deploy 5G-connected continuous cardiac telemetry patches, cellular blood pressure monitors, and smart pulse oximeters to manage cardiopulmonary disease across both urban centers and rural northern communities. In Indiana, Indianapolis serves as a major biomedical and pharmaceutical hub, with health systems such as Indiana University Health deploying 5G-enabled clinical mobility tools, smart beds, and pharmacy automation systems across extensive statewide facilities. Wisconsin, anchored by Advocate Aurora Health, Froedtert Health, and the University of Wisconsin Hospitals, features extensive adoption of 5G-connected remote patient monitoring and cellular drug delivery pumps to manage chronic metabolic conditions across both urban and rural dairy farming populations.

Minnesota, Iowa, Missouri, and the Plains States—including Kansas, Nebraska, and the Dakotas—represent critical centers of clinical innovation and agricultural rural healthcare infrastructure. Minnesota is globally renowned as the home of the Mayo Clinic in Rochester, consistently recognized as the premier hospital system in the world. Mayo Clinic has spearheaded the clinical deployment of enterprise private 5G cellular networks, collaborating with leading telecommunications and medical device corporations to test and deploy 5G-connected wearable biosensors, automated surgical navigation systems, and decentralized hospital-at-home platforms that redefine clinical standards of care globally. Concurrently, the Twin Cities of Minneapolis and St. Paul represent one of the world’s most concentrated medical device engineering corridors, housing major research and manufacturing operations for tier-one medtech leaders. In Missouri, major health systems in St. Louis and Kansas City, including BJC HealthCare and Saint Luke’s Health System, have deployed 5G-connected ambulance fleets and mobile stroke units. Across Iowa, Kansas, Nebraska, and the Dakotas, where healthcare facilities are separated by vast agricultural distances, health systems and regional critical access networks rely on low-band and mid-band public 5G cellular medical devices to transmit diagnostic ultrasound, continuous ECG telemetry, and digital pathology scans from isolated community clinics to centralized specialty referral centers.

Capital procurement behavior across the Midwest is characterized by deep clinical rigor, disciplined financial analysis, and an unwavering focus on total cost of ownership. Midwestern healthcare executives and biomedical engineering committees thoroughly evaluate clinical trial data, workflow labor efficiency metrics, and equipment durability before committing to large-scale fleet conversions. Medical device manufacturers succeed in this region by demonstrating that their 5G-connected hardware delivers measurable clinical labor savings, reduces preventable hospital readmissions, integrates seamlessly with existing electronic health records, and is backed by robust, dependable regional field engineering support.

Northeast

The Northeast represents an exceptionally sophisticated, high-value, and clinically intensive market for 5G connected medical devices, accounting for USD 3.65 billion in 2026, having grown from USD 1.72 billion in 2023, USD 2.21 billion in 2024, and USD 2.83 billion in 2025. The Northeastern market is projected to reach USD 11.95 billion by 2032, advancing at a CAGR of 21.86% from 2027 to 2032. While the Northeast is geographically more compact than the other commercial regions, it features the highest geographic density of elite academic medical centers, prestigious medical research universities, comprehensive cancer centers, and cutting-edge biotechnology clusters in the world. Healthcare facilities in this region manage exceptionally complex, high-acuity patient caseloads and possess the institutional capital and technical expertise required to lead early adoption of advanced medical device technologies.

New York represents the preeminent commercial market within the Northeast, driven by the massive concentration of world-class medical institutions across the New York City metropolitan area, Long Island, and Westchester County, complemented by extensive upstate healthcare networks. New York City hosts premier healthcare giants, including NewYork-Presbyterian Hospital, Mount Sinai Health System, NYU Langone Health, Memorial Sloan Kettering Cancer Center, and Montefiore Health System. These massive urban health systems operate in dense vertical architectural environments where traditional Wi-Fi networks suffer from severe radiofrequency interference and structural signal attenuation caused by steel, dense concrete, and thousands of competing unlicensed wireless networks. To overcome these urban RF barriers, New York health systems have aggressively deployed private 5G cellular networks and distributed antenna systems operating on dedicated CBRS spectrum. These networks support thousands of 5G-connected transport monitors, smart hospital beds, mobile robotic tele-presence systems, and wireless surgical visualization displays across high-acuity operating rooms and intensive care units. In upstate New York, health systems such as the University of Rochester Medical Center and Albany Medical Center deploy 5G-connected remote patient monitoring kits and cellular mobile stroke units to manage diverse populations across suburban and rural Adirondack communities.

Pennsylvania represents the second-largest state market within the Northeast, supported by two major medical innovation epicenters in Philadelphia and Pittsburgh. In eastern Pennsylvania, the Philadelphia metropolitan region features world-renowned healthcare institutions, including Penn Medicine, Thomas Jefferson University Hospitals, and the Children’s Hospital of Philadelphia. Penn Medicine has deployed enterprise 5G private networks to support real-time digital pathology whole-slide imaging transmission, continuous inpatient biometric telemetry, and augmented reality surgical navigation suites. In western Pennsylvania, the University of Pittsburgh Medical Center (UPMC) operates as a global healthcare titan and integrated delivery and finance system. UPMC leverages its integrated payer-provider structure to deploy 5G connected medical devices across thousands of chronic disease patients, utilizing continuous 5G telemetry, cellular continuous glucose monitors, and connected smart infusion pumps to optimize outpatient management, reduce hospitalization costs, and eliminate unnecessary clinical interventions.

Massachusetts, New Jersey, and Connecticut represent exceptionally affluent, technology-dense healthcare markets characterized by world-leading medical research and high rates of clinical trial activity. The Boston metropolitan area serves as an undisputed global capital of medical technology, biotechnology, and academic medicine, anchored by Mass General Brigham (encompassing Massachusetts General Hospital and Brigham and Women’s Hospital), Beth Israel Deaconess Medical Center, and Boston Children’s Hospital. Mass General Brigham has executed pioneering clinical deployments of private 5G infrastructure, collaborating with device manufacturers to validate 5G-connected wearable biosensors, automated closed-loop drug delivery pumps, and high-bandwidth edge-AI surgical robotics platforms. In New Jersey, health systems such as Hackensack Meridian Health and RWJBarnabas Health have deployed extensive 5G remote patient monitoring networks across the state’s dense suburban populations to manage cardiovascular disease and post-surgical recovery. In Connecticut, the Yale New Haven Health system has integrated 5G-connected mobile telemetry and digital diagnostic tools across its hospital facilities and ambulatory surgery centers, optimizing surgical turnover times and inpatient clinical surveillance.

Northern New England—encompassing Maine, New Hampshire, and Vermont—completes the Northeastern regional landscape, representing a specialized, high-demand market for rural 5G connected medical technologies. Prominent regional health systems, including MaineHealth, Dartmouth Health in New Hampshire, and the University of Vermont Health Network, manage vast rural and mountainous populations characterized by aging demographics and limited local access to specialty clinical care. These systems invest heavily in low-band and mid-band public 5G-connected medical devices, deploying cellular remote patient monitoring kits, 5G-connected mobile digital mammography vans, and cellular point-of-care ultrasound devices to rural community health centers. Paramedics and home nursing personnel throughout northern New England utilize ruggedized 5G emergency gateways to transmit high-resolution clinical data and live tele-consultation video from isolated domestic and accident locations directly to academic tertiary medical specialists, safeguarding rural clinical access.

Procurement dynamics across the Northeast are intensely evidence-based, clinically rigorous, and focused on cutting-edge innovation. With the nation’s highest concentration of clinical department chairs, specialized medical researchers, and biomedical engineering faculty, Northeastern purchasing committees demand exhaustive clinical efficacy data, uncompromising electrical and wireless safety profiles, and validated compatibility with enterprise hospital information architecture. Medical device vendors consistently achieve their highest premium valuations and early-adopter commercial validation within this scientifically demanding regional healthcare market.

Key Market Players

The competitive ecosystem of the U.S. 5G Connected Medical Devices Market is defined by a strategic convergence between diversified multinational medical technology corporations, specialized clinical monitoring pioneers, agile biometric sensor innovators, and global clinical diagnostic giants.

Highly relevant players operating in the U.S. 5G connected medical devices industry include:

Medtronic plc
GE HealthCare Technologies Inc.
Baxter International Inc.
Abbott Laboratories
Boston Scientific Corporation
Philips Healthcare
Siemens Healthineers AG
Stryker Corporation
Masimo Corporation
Dexcom, Inc.
Becton, Dickinson and Company (BD)
ResMed Inc.
iRhythm Technologies, Inc.
Zimmer Biomet Holdings, Inc.
Omnicell, Inc.

Medtronic plc commands a formidable, industry-leading presence across the connected medical device landscape, leveraging its expansive biomedical engineering heritage to pioneer 5G-connected surgical navigation, continuous cardiac telemetry, and neuromodulation platforms. Medtronic’s strategic orientation focuses on embedding direct cellular connectivity and edge-computed intelligence into its next-generation capital surgical hardware and implantable patient monitoring ecosystems. The company has integrated high-speed cellular gateways into its stealth surgical navigation platforms and robotic-assisted spine surgical systems, enabling real-time intraoperative data streaming and remote technical proctoring. Furthermore, Medtronic’s cardiac rhythm management division has commercialized insertable cardiac monitors and pacemaker telemetry hubs that utilize low-power cellular protocols to stream continuous arrhythmia alerts directly to the CareLink cloud network, eliminating domestic Wi-Fi setup barriers for elderly cardiac patients and securing continuous clinical oversight.

GE HealthCare Technologies Inc. represents a preeminent cornerstone of the hospital-wide clinical telemetry, diagnostic imaging, and enterprise critical care monitoring market. GE HealthCare has established deep, systemic partnerships with major telecommunications carriers and cloud hyperscalers to engineer private 5G-enabled patient monitoring workstations and diagnostic imaging systems. Its flagship patient monitoring platforms, such as the CARESCAPE series, feature native compatibility with enterprise private 5G cellular networks, enabling uncompromised multi-parameter vital signs streaming and telemetry mobility across acute hospital complexes without risk of Wi-Fi packet dropouts. In diagnostic imaging, GE HealthCare has commercialized handheld, wireless point-of-care ultrasound devices, including the Vscan Air family, which leverage 5G enhanced mobile broadband to stream raw ultrasound data to multi-access edge computing servers, allowing automated artificial intelligence algorithms to calculate ejection fractions and detect abnormalities in seconds.

Baxter International Inc. occupies a dominant, highly defensible market position across acute critical care workstations, smart hospital beds, and clinical infusion therapy systems. Following its landmark integration of Hillrom, Baxter established an unparalleled footprint in connected inpatient care architecture. The company has engineered native 5G connectivity into its Centrella and Progressa smart hospital bed platforms, which continuously stream real-time patient weight, continuous contact-free heart rate, respiratory rates, and patient movement metrics over private cellular networks directly to centralized nurse communication dashboards, eliminating manual charting and preventing pressure ulcers and inpatient falls. Furthermore, Baxter’s smart infusion systems utilize continuous cellular pipelines to maintain continuous synchronization with hospital pharmacy drug error reduction systems, downloading updated formulary dose limits and clinical guidelines across vast multi-facility pump fleets automatically.

Abbott Laboratories is a global titan in outpatient metabolic monitoring, cardiovascular telemetry, and point-of-care diagnostics. Abbott has transformed chronic disease management through its revolutionary FreeStyle Libre continuous glucose monitoring platform, establishing unmatched global market penetration. Abbott has integrated native, ultra-low-power cellular connectivity directly into its continuous glucose sensor ecosystem, removing the absolute requirement for companion consumer smartphones and ensuring uninterrupted, automated transmission of real-time interstitial glucose metrics, glycemic rate-of-change velocity, and acute hypoglycemia alarms directly to clinical monitoring portals and family care networks. In cardiovascular care, Abbott’s insertable cardiac monitors and CardioMEMS heart failure monitoring systems utilize cellular communication units to stream pulmonary artery hemodynamic pressures directly to clinical cardiologists, facilitating proactive medication titrations that dramatically reduce hospital readmissions.

Boston Scientific Corporation maintains a leading competitive position across interventional cardiology, electrophysiology, endoscopy, and neuromodulation medical technologies. Boston Scientific differentiates itself through its comprehensive LATITUDE NXT patient management system, which provides continuous, automated cellular surveillance for patients with implantable cardiac pacemakers, cardioverter-defibrillators, and cardiac resynchronization therapy devices. The company’s cellular telemetry transmitters autonomously capture and transmit complex intracardiac electrograms, device battery status, and lead impedance measurements to clinical electrophysiologists over commercial cellular networks without patient intervention. Additionally, Boston Scientific is pioneering the integration of 5G enhanced mobile broadband transceivers into single-use digital endoscopes and visual navigation processors, enabling ultra-low-latency transmission of high-definition intracorporeal procedural video to cloud surgical repositories and remote expert consultation hubs.

Philips Healthcare, operating through Philips North America, represents an international benchmark in connected hospital patient monitoring, clinical informatics, and sleep and respiratory medicine. Philips commands a vast installed base of critical care bedside monitors, telemetry transmitters, and centralized clinical surveillance software across American integrated delivery networks. Philips has aggressively re-engineered its IntelliVue patient monitoring ecosystem to interface natively with enterprise private 5G cellular infrastructure and Citizens Broadband Radio Service spectrum, providing guaranteed deterministic quality of service and microsecond-level synchronization for life-critical patient alarms. Through its enterprise virtual care and telemetry solutions, Philips links bedside 5G monitors with regional virtual nursing and tele-ICU command centers, allowing remote intensivist physicians and specialized nurses to oversee clinical care across dozens of geographically dispersed hospital facilities simultaneously.

Siemens Healthineers AG, through its Siemens Medical Solutions USA subsidiary, is a global leader in high-end diagnostic imaging, advanced laboratory diagnostics, and minimally invasive image-guided therapy. Siemens Healthineers has pioneered the integration of 5G telecommunications into mobile medical imaging, digital pathology, and remote interventional proctoring. The company commercialized advanced teleradiology and tele-intervention platforms that utilize high-bandwidth, ultra-low-latency 5G slices to stream massive volumetric cross-sectional CT and MRI datasets, alongside real-time interventional fluoroscopy feeds, to remote imaging specialists. Its 5G-connected Mobile Stroke Unit CT platforms allow hospital neurosurgeons to review raw cross-sectional brain scans and direct pre-hospital thrombolytic therapy while patients are in transit. Furthermore, Siemens Healthineers leverages 5G networks to conduct remote expert scanning assistance, enabling centralized expert technologists to control complex MRI scanners located in rural community hospitals miles away.

Stryker Corporation is a preeminent leader in orthopedic capital equipment, operating room surgical infrastructure, emergency medical hardware, and surgical navigation. Stryker has revolutionized the digital operating room through its iSuite surgical environment and Mako robotic-assisted surgical platforms. Stryker is actively embedding high-frequency millimeter-wave and sub-6 GHz 5G modems into its surgical visualization towers, operating room displays, and wireless surgical cameras, eliminating hazardous video cabling across the sterile operating room floor while streaming uncompressed 4K and 8K surgical video with imperceptible latency. In emergency medical services, Stryker’s Emergency Care division leads the market with its LIFEPAK series of connected defibrillators and Lucas mechanical chest compression systems. These mission-critical devices leverage cellular gateways to stream real-time 12-lead diagnostic ECG waveforms, continuous end-tidal CO2 curves, and CPR quality metrics directly to receiving emergency department physicians during active resuscitation.

Masimo Corporation represents a premier clinical innovator in non-invasive patient monitoring, advanced optical sensor technology, and hospital automation architecture. Masimo is celebrated globally for its Signal Extraction Technology pulse oximetry, which eliminates false alarms and accurately measures blood oxygen saturation and pulse rate during active patient motion and low peripheral perfusion. Masimo has established a formidable position in connected hospital and home healthcare through its Masimo SafetyNet and Radius-7 wireless wearable multi-parameter sensors. The company has integrated direct 5G cellular connectivity into its Patient SafetyNet central surveillance systems and wearable biosensors, allowing hospital systems to extend continuous physiological surveillance seamlessly from inpatient intensive care units into decentralized hospital-at-home wards, streaming continuous pulse rate, oxygen saturation, respiration rate, and acoustic capnography directly to clinical dashboards.

Dexcom, Inc. is a globally recognized pioneer specializing exclusively in real-time continuous glucose monitoring technology for patients with type 1 and type 2 diabetes. Dexcom has redefined metabolic clinical management through its flagship G-series continuous glucose monitoring platforms. Dexcom has led the integration of direct cellular micro-transceivers and low-power 5G RedCap silicon into its continuous glucose sensor transmitters, creating standalone continuous monitoring devices that operate completely independently of consumer smartphones. This autonomous cellular capability ensures that continuous glucose metrics, predictive hypoglycemia warnings, and rate-of-change trend vectors are beamed directly to cloud-based clinical management portals, pediatric caregiver dashboards, and automated emergency alert systems, eliminating data gaps caused by patient phone connectivity issues, dead smartphone batteries, or software crashes.

Becton, Dickinson and Company (BD) is an indispensable titan of the American healthcare infrastructure, commanding massive market shares in clinical infusion therapy, medication management systems, and diagnostic consumables. BD’s Medication Management Solutions division dominates the institutional hospital market through its renowned BD Alaris smart infusion pump system and automated medication dispensing platforms. BD is actively deploying native 5G wireless connectivity across its enterprise infusion pump fleets, establishing persistent, encrypted cellular connections to hospital pharmacy management networks. This continuous 5G connection enables hospital pharmacies to wirelessly deploy institutional drug libraries, update dosage error reduction boundaries, push cybersecurity patches, and capture granular medication administration logs across thousands of active infusion pumps across multi-building medical centers without taking pumps out of clinical operation.

ResMed Inc. is a global leader in connected sleep apnea therapies, non-invasive mechanical ventilation, and out-of-hospital clinical software platforms. ResMed operates one of the world’s largest deployed fleets of connected medical hardware, having integrated cellular modems as a standard architectural feature across millions of its continuous positive airway pressure (CPAP) and bi-level positive airway pressure (BiPAP) devices. ResMed is transitioning its sleep and respiratory therapy fleet to native 5G cellular connectivity, utilizing low-band cellular protocols to transmit comprehensive overnight therapy data, including mask leak rates, apnea-hypopnea index scores, tidal volumes, and therapeutic usage compliance logs, directly to its cloud-based AirView clinical portal. This automated cellular pipeline provides sleep physicians and durable medical equipment providers with continuous clinical compliance data, streamlining CMS reimbursement documentation and facilitating proactive mask and pressure titrations that dramatically improve long-term patient therapy adherence.

iRhythm Technologies, Inc. is a leading digital healthcare and biometric monitoring company that has disrupted ambulatory cardiac arrhythmia detection through its Zio wearable cardiac telemetry service. iRhythm combines wearable continuous ECG patch biosensors with deep learning artificial intelligence algorithms to detect intermittent, occult arrhythmias such as paroxysmal atrial fibrillation, ventricular tachycardia, and pauses. iRhythm’s next-generation Zio monitors feature integrated direct-to-cellular 5G modems that transmit captured arrhythmia episodes and multi-lead ECG waveforms directly to iRhythm’s clinical diagnostic center in real time. This immediate cellular transmission eliminates historical delays associated with physical mail-in cardiac monitors, empowering clinical electrophysiologists to diagnose dangerous, life-threatening arrhythmias rapidly and initiate anticoagulation or catheter ablation therapy before catastrophic stroke occurs.

Zimmer Biomet Holdings, Inc. is a global medical technology powerhouse in musculoskeletal healthcare, orthopedic joint reconstruction, and surgical robotics. Zimmer Biomet is advancing the connected orthopedic care continuum through its ZBEdge connected intelligence suite, which integrates the ROSA robotic-assisted surgical platform, mymobility virtual care patient management platform, and Persona IQ smart knee implant. Zimmer Biomet’s Persona IQ represents a landmark breakthrough in orthopedic implant technology, integrating embedded kinematic micro-sensors directly within the tibial stem of a total knee arthroplasty implant. The company leverages 5G connected medical hubs to capture daily step counts, walking speed, range of motion, and joint cadence metrics transmitted by the smart implant, streaming kinematic data directly to orthopedic surgeon dashboards to track objective physical recovery and identify sub-clinical joint failure without requiring patient manual charting.

Omnicell, Inc. is a preeminent provider of automated medication management systems, autonomous pharmacy dispensing infrastructure, and advanced clinical supply telematics. Omnicell’s connected pharmacy robotics, automated dispensing cabinets, and smart medication adherence packaging systems form the logistics and medication safety backbone of thousands of American hospital systems. Omnicell is actively deploying private 5G cellular interfaces across its automated dispensing cabinets and mobile medication administration carts, establishing secure, high-speed wireless connections to hospital central pharmacy mainframes. This private 5G cellular backbone guarantees uninterrupted real-time inventory decrementing, controlled substance biometric authentication, automated restock dispatch, and closed-loop electronic health record verification across complex multi-facility hospital systems, completely removing medication dispensing carts from congested hospital Wi-Fi networks and eliminating dispensing latencies.

Recent Developments

The U.S. 5G connected medical devices industry has undergone profound corporate consolidation, technological acceleration, and regulatory transformation since 2024.

A defining structural development has been the systematic deployment of enterprise private 5G cellular networks across tier-one integrated delivery networks, led by landmark installations across Mayo Clinic, Cleveland Clinic, Duke University Health System, and Kaiser Permanente. Between 2024 and 2026, these leading healthcare systems transitioned from evaluating private cellular technology in isolated innovation pilots toward executing multi-facility, enterprise-wide deployments of Citizens Broadband Radio Service OnGo private 5G networks. In collaboration with telecommunications infrastructure providers and cloud hyperscalers, these healthcare networks deployed dedicated on-premise 5G radio access networks, localized micro-edge computing appliances, and carrier-agnostic small cell networks across acute inpatient towers, emergency trauma complexes, and surgical suites. By establishing dedicated, interference-free private cellular infrastructure operating on protected spectrum, these hospital systems have successfully onboarded thousands of 5G-enabled smart infusion pumps, transport vital signs monitors, and mobile clinical communication badges, completely isolating life-critical medical telemetry from external public telecommunications traffic and consumer Wi-Fi congestion.

Strategic corporate mergers, acquisitions, and commercial partnerships have simultaneously reshaped competitive positioning across the connected medtech landscape. Medical technology conglomerates have executed aggressive transactions to acquire specialized wireless biomedical sensor startups, edge artificial intelligence software developers, and cloud telematics platforms. Leading medical device corporations have formed direct strategic enterprise partnerships with major telecommunications carriers, including AT&T for Business, Verizon Business, and T-Mobile for Business. These cross-industry alliances have yielded unified commercial offerings wherein medical device manufacturers bundle enterprise hardware, native 5G multi-carrier eSIM connectivity, carrier-managed private network slices, and automated EHR integration into multi-year capital-as-a-service contracts, significantly reducing upfront capital expenditure hurdles for community hospital networks and outpatient surgical centers.

Product innovation within 5G Reduced Capability medical silicon achieved commercial breakthroughs between late 2024 and early 2026. Semiconductor manufacturers and biomedical engineering teams successfully cleared pre-market regulatory hurdles for single-die 3GPP Release 17 and Release 18 5G RedCap medical system-on-chip architectures. The commercial availability of these miniaturized, power-efficient chipsets enabled tier-one medical device vendors to launch featherweight, skin-adherent wearable biosensors, continuous glucose monitors, and disposable patient monitoring patches with integrated native cellular modems. These next-generation 5G RedCap devices eliminate the historical necessity for external paired cellular hubs, physical dongles, or patient companion smartphones, achieving single-charge operating lifespans exceeding two weeks and reducing cellular bill-of-materials manufacturing costs by over 45%, unlocking widespread commercialization across mass-market outpatient chronic care programs.

Pre-hospital emergency medical services have undergone an engineering transformation through the nationwide deployment of 5G-connected mobile stroke units and advanced life support tele-triage fleets. Leading municipal fire departments, regional emergency medical networks, and private ambulance operators across major metropolitan corridors—including Houston, New York City, Chicago, Atlanta, and Los Angeles—have retrofitted frontline emergency vehicles with ruggedized 5G multi-network vehicular gateways, mobile point-of-care whole-body ultrasound systems, and portable multi-slice CT scanners. Transmitting uncompressed neuroimaging scans and multi-angle high-definition tele-consultation video streams over high-bandwidth 5G carrier networks has slashed pre-hospital diagnostic times for acute stroke and trauma patients by an average of 35 minutes, allowing emergency medical teams to administer targeted intravenous thrombolytics and prepare neuro-interventional surgical suites before the ambulance arrives at the hospital bay.

The regulatory and cybersecurity landscape has simultaneously experienced profound structural modernization administered by the Food and Drug Administration and the Federal Communications Commission. Under Section 524B of the Federal Food, Drug, and Cosmetic Act, the FDA enacted stringent, legally binding cybersecurity requirements for all cyber devices seeking pre-market 510(k), De Novo, or Premarket Approval clearances. Medical device manufacturers are now legally mandated to demonstrate comprehensive software bills of materials, robust zero-trust cryptographic verification, secure boot firmware, and validated wireless coexistence capabilities to prevent dangerous radiofrequency packet collisions in dense RF environments. Concurrently, the FCC expanded commercial allocations and secondary licensing frameworks within mid-band C-Band and 3.5 GHz CBRS spectrum, expediting hospital approvals for on-premise private cellular basestations. These regulatory mandates have accelerated capital modernization across healthcare systems, compelling hospital purchasing committees to decommission vulnerable, unmanaged legacy Wi-Fi medical hardware in favor of highly secure, encrypted 5G cellular systems.

Furthermore, the Centers for Medicare and Medicaid Services continuously expanded and codified its reimbursement frameworks for remote physiological monitoring, remote therapeutic monitoring, and principal illness navigation. Between 2024 and 2026, CMS introduced revised valuation schedules and operational clarifications for CPT codes 99453, 99454, 99457, 99458, 98975, 98976, 98977, 98980, and 98981, allowing clinical practices to bill for continuous biometric telemetry and algorithmic AI-assisted physiological data analysis with reduced administrative friction. These expanded reimbursement pathways, combined with aggressive quality scoring bonuses under Medicare Advantage Star Ratings and Merit-based Incentive Payment Systems, have provided physician groups and accountable care organizations with durable, predictable cash flows to invest in large-scale deployments of 5G connected medical hardware for outpatient chronic disease cohorts.

Conclusion

The U.S. 5G Connected Medical Devices Market Size & Share is positioned to expand from USD 25.18 billion in 2026 to approximately USD 84.72 billion by 2032, supported by a CAGR of 22.41% during the forecast period 2027–2032. Historical market development from USD 11.45 billion in 2023, USD 14.88 billion in 2024, and USD 19.35 billion in 2025 demonstrates the structural resilience, capital modernization, and rapid clinical integration of fifth-generation cellular medical hardware across macroeconomic and healthcare policy cycles.

The underlying growth thesis is propelled by irreversible structural transformations within the American healthcare delivery landscape. Persistent clinical labor shortages, unprecedented chronic disease burdens across an aging population, and the escalating financial penalties associated with acute inpatient hospital readmissions have compelled healthcare leaders to decentralize clinical care. Acute, sub-acute, and chronic healthcare interventions are permanently migrating into community outpatient facilities, connected emergency vehicles, and domestic home environments, establishing an absolute clinical prerequisite for unbroken, deterministic, high-bandwidth cellular medical communication links.

The commercial marketplace is defined by the decisive migration away from unreliable, interference-prone domestic and hospital Wi-Fi networks in favor of native 5G cellular architectures. Contemporary healthcare providers require purpose-engineered medical hardware incorporating native 5G RedCap biomedical silicon, zero-trust cryptographic security, automated dynamic network slicing, multi-access edge computing, and seamless interoperability with core electronic health record platforms. These advanced cellular platforms eliminate patient onboarding friction, guarantee uninterrupted physiological alarm transmission, and provide hospital Chief Information Security Officers with complete network isolation and robust cybersecurity protection.

Remote patient monitoring and wearable biosensors will maintain their position as the premier product category by volume and clinical deployment, driven by the aggressive expansion of hospital-at-home programs, CMS reimbursement support, and continuous closed-loop metabolic and cardiopulmonary surveillance. Concurrently, connected diagnostic imaging platforms, enterprise critical care telemetry workstations, smart infusion systems, and extended reality surgical guidance consoles will capture substantial, recurring capital value through enterprise hospital private 5G network standardizations and multi-year cellular service integrations.

Geographically, the South will maintain absolute commercial revenue leadership, propelled by massive demographic in-migration, the highest regional prevalence of chronic metabolic and cardiovascular disease in the nation, expansive rural geographies requiring remote healthcare lifelines, and aggressive private 5G investments across massive commercial healthcare systems in Texas and Florida. The West will continue to lead the nation in technological growth velocity, driven by California’s cutting-edge digital health innovation ecosystem, concentrated venture capital funding, progressive telehealth reimbursement policies, and early institutional adoption of private 5G networks across premier academic medical centers. The Midwest will continue to provide a deeply resilient foundation of capital equipment procurement across world-renowned tertiary clinical hubs and expansive rural hospital networks, governed by disciplined capital budgeting and an intense focus on clinical return on investment. The Northeast will remain the country’s most specialized, research-intensive regional market, distinguished by elite academic medical teaching hospitals and comprehensive cancer centers that set national benchmarks for complex surgical robotics, digital pathology whole-slide transmission, and advanced clinical care delivery.

For medical device manufacturers, telecommunications carriers, cloud hyperscalers, and institutional investors, competitive advantage through 2032 will belong to enterprises that deliver comprehensive, end-to-end connected clinical ecosystems. Physical device excellence alone is no longer sufficient to secure long-term market dominance. Winning medtech organizations will successfully unite high-reliability physical medical hardware with native 5G cellular silicon, certified zero-trust cybersecurity architectures, automated edge artificial intelligence inference, pre-negotiated multi-carrier cellular connectivity, seamless EHR interoperability, and dedicated nationwide clinical support services. Companies that master this integrated clinical workflow and telecommunications paradigm will capture the greatest enterprise lifetime value and define the standard of patient care across the expanding U.S. 5G connected medical devices landscape through 2032.